Triple
T21867226
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Kenneth G. Langone |
E539911
|
entity |
| Predicate | founderOf |
P104
|
FINISHED |
| Object | Invemed Associates LLC |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Invemed Associates LLC | Statement: [Kenneth G. Langone, founderOf, Invemed Associates LLC]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Invemed Associates LLC Context triple: [Kenneth G. Langone, founderOf, Invemed Associates LLC]
-
A.
Invemed Associates LLC
chosen
Invemed Associates LLC is a New York–based investment banking and brokerage firm founded by financier Kenneth G. Langone, known for its role in early-stage corporate financing.
-
B.
Innogen
Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
-
C.
Idun Pharmaceuticals
Idun Pharmaceuticals is a biotechnology company focused on developing therapies that regulate cell death pathways, particularly apoptosis, for the treatment of various diseases.
-
D.
Innovium, Inc.
Innovium, Inc. was a semiconductor company specializing in high-performance Ethernet switch silicon for data centers and cloud infrastructure.
-
E.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0c478f59081909d54302b57fc1ce3 |
completed | April 16, 2026, 11:14 a.m. |
| NER | Named-entity recognition | batch_69f0f331c55c8190b73cb5aec3378a9e |
completed | April 28, 2026, 5:49 p.m. |
Created at: April 16, 2026, 6:57 p.m.